Cargando…

Governance of preventive Health Intervention and On time Verification of its Efficiency: the GIOVE Study

OBJECTIVES: The GIOVE Study was aimed to the achievement of allocative efficiency of the budget allocated to the prevention of human papillomavirus (HPV)-induced diseases. An ex-ante determination of the most efficient allocation of resources between screening and multicohort quadrivalent immunisati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mennini, Francesco Saverio, Baio, Gianluca, Montagano, Giuseppe, Cauzillo, Gabriella, Locuratolo, Francesco, Becce, Gerardo, Gitto, Lara, Marcellusi, Andrea, Zweifel, Peter, Capone, Alessandro, Favato, Giampiero
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Group 2012
Materias:	Health Economics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307037/ https://www.ncbi.nlm.nih.gov/pubmed/22422918 http://dx.doi.org/10.1136/bmjopen-2011-000736

Ejemplares similares

Correction: Economic Burden of Human Papillomavirus-Related Diseases in Italy
por: Baio, Gianluca, et al.
Publicado: (2013)

Economic Burden of Human Papillomavirus-Related Diseases in Italy
por: Baio, Gianluca, et al.
Publicado: (2012)

Transparency or Proper Study Valuation Procedures Missed?
por: Favato, Giampiero, et al.
Publicado: (2013)

Economic burden of schizophrenia in Italy: a probabilistic cost of illness analysis
por: Marcellusi, Andrea, et al.
Publicado: (2018)

The costs of headache disorders
por: Mennini, Francesco Saverio, et al.
Publicado: (2015)

Human papillomavirus in Italy: retrospective cohort analysis and preliminary vaccination effect from real-world data
por: Marcellusi, A., et al.
Publicado: (2021)

Hospital resource utilisation from HPV-related diseases in England: a real-world cost analysis
por: Fabiano, G., et al.
Publicado: (2022)

Improving care through health economics analyses: cost of illness and headache
por: Mennini, Francesco Saverio, et al.
Publicado: (2008)

The Impact of COVID-19 Vaccination on the Italian Healthcare System: A Scenario Analysis
por: Marcellusi, Andrea, et al.
Publicado: (2022)

Costo-efficacia di IMI/CIL/REL rispetto a CMS+IMI per il trattamento di infezioni batteriche Gram-negative non sensibili ai carbapenemi
por: Paoletti, Martina, et al.
Publicado: (2023)

Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2018)

Estimation of the number of HCV-positive patients in Italy
por: Gardini, Ivan, et al.
Publicado: (2019)

Valutazione delle conseguenze epidemiologiche ed economiche generate dal ritardo di trattamento dei pazienti HIV-positivi causato dalla pandemia COVID-19
por: Marcellusi, Andrea, et al.
Publicado: (2021)

Analisi di impatto di budget di un nuovo sistema di cura in pazienti affetti da malattia di Parkinson
por: Bini, Chiara, et al.
Publicado: (2022)

Valutazione economica di treosulfan in pazienti sottoposti a trapianto allogenico di cellule staminali ematopoietiche
por: Bini, Chiara, et al.
Publicado: (2022)

Cost of illness del carcinoma cutaneo a cellule squamose (CSCC)
por: Marcellusi, Andrea, et al.
Publicado: (2020)

Health policy model: long-term predictive results associated with the management of hepatitis C virus-induced diseases in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2014)

HPV Vaccination during the COVID-19 Pandemic in Italy: Opportunity Loss or Incremental Cost
por: Mennini, Francesco Saverio, et al.
Publicado: (2022)

Analisi di costo-utilità di ceftolozano/tazobactam rispetto a meropenem in pazienti con polmonite acquisita in ospedale (HABP) o polmonite associata a ventilazione meccanica (VABP)
por: Mennini, Francesco Saverio, et al.
Publicado: (2022)

Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling Analysis
por: Marcellusi, Andrea, et al.
Publicado: (2021)

ASSET (Age/Sex Standardised Estimates of Treatment): A Research Model to Improve the Governance of Prescribing Funds in Italy
por: Favato, Giampiero, et al.
Publicado: (2007)

Analisi di costo-utilità di evolocumab in pazienti con ASCVD in Italia
por: Marcellusi, Andrea, et al.
Publicado: (2021)

Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2017)

Costo-utilità di dalbavancina versus standard of care (SoC) in pazienti con ABSSSI non severa in Italia
por: Marcellusi, Andrea, et al.
Publicado: (2020)

Monetary costs of agitation in older adults with Alzheimer's disease in the UK: prospective cohort study
por: Morris, Stephen, et al.
Publicado: (2015)

Economic evaluation of spondyloarthritis: economic impact of diagnostic delay in Italy
por: Mennini, Francesco S, et al.
Publicado: (2018)

Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system
por: Riva, Silvia, et al.
Publicado: (2021)

The potential impact of PNNR on the management of patients with epilepsy
por: Mennini, Francesco Saverio
Publicado: (2022)

Risk of Exposure to COVID-19: Visit Duration Data Can Inform Our Daily Activities Choices: An Epidemiological Investigation Using Community Mobility Data from the Metropolitan Area of Genoa, Italy
por: Oliva, Cristina, et al.
Publicado: (2021)

From 15 Minutes to 15 Seconds: How the Delta Variant Changed the Risk of Exposure to COVID-19. A Comparative Epidemiological Investigation Using Community Mobility Data From the Metropolitan Area of Genoa, Italy
por: Oliva, Cristina, et al.
Publicado: (2022)

The Economic Shock of the Health Crisis in 2020: Comparing the Scale of Governments Support
por: Jacques Sapir
Publicado: (2021)

Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation
por: Marcellusi, Andrea, et al.
Publicado: (2021)

An Analysis of the Social and Economic Costs of Breast Cancer in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2021)

Refining the provider payment system of India’s government-funded health insurance programme: an econometric analysis
por: Prinja, Shankar, et al.
Publicado: (2023)

Longitudinal analysis of local government spending on adult social care and carers’ subjective well-being in England
por: Zhang, Yanan, et al.
Publicado: (2021)

Ecological validity of cost-effectiveness models of universal HPV vaccination: a protocol for a systematic review
por: Favato, Giampiero, et al.
Publicado: (2017)

Government, industry, accelerators
por: Roche, C
Publicado: (1996)

Understanding public preferences and trade-offs for government responses during a pandemic: a protocol for a discrete choice experiment in the UK
por: Genie, Mesfin G, et al.
Publicado: (2020)

Socio-economic impact of epilepsy in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2022)

Understanding government contract law
por: O'Connor, Terrence M
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jbm9aklo742385oblocvs2opb3